MedPath

Effect of supplementation of chromium in glucose of diabetic patients

Not Applicable
Conditions
Type 2 Diabetes Mellitus
C18.452.394.750.149
Registration Number
RBR-79nxr8
Lead Sponsor
niversidade Feral do Rio Grande do Norte
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruitment completed
Sex
Not specified
Target Recruitment
Not specified
Inclusion Criteria

Volunteers diagnosed with type two diabetes mellitus according to the criteria of the American Diabetes Association two thousand and eleven; both genders; presenting glycated hemoglobin greater than or equal to seven percent; not in use of insulin; age between thirty and seventy years; not have taked mineral vitamin supplement in the last three months

Exclusion Criteria

Volunteers taking insulin and / or corticosteroids; showing endocrinopathy (cushin syndrome; acromegaly; hyper or uncontrolled hypothyroidism); kidney disease; cancer; infection and anemia; pregnant women; lactating women

Study & Design

Study Type
Intervention
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Improvement in glycemic control (fasting blood glucose, postprandial blood glucose and glycated hemoglobin), after 4 months of supplementation with chromium picolinate compared the differences between the groups;The glycemic profile (fasting blood glucose, postprandial blood glucose and glycated hemoglobin) showed improvement after 4 months of supplementation with chromium picolinate, compared the differences between the groups
Secondary Outcome Measures
NameTimeMethod
Improvement in lipid profile (total cholesterol, HDL cholesterol, LDL cholesterol and triglycerides), after 4 and 8 months of supplementation with chromium picolinate compared the differences between the groups;No improvement was found in the lipid profile (total cholesterol, HDL cholesterol, LDL cholesterol and triglycerides)after 4 months of supplementation with chromium picolinate, compared the differences between the groups
© Copyright 2025. All Rights Reserved by MedPath